The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 3

More JCP Articles

JCP
Opioid Use Disorder Treatment in Sexually and Gender Diverse Patients
Original Research

October 30, 2024

The disparities in buprenorphine prescriptions and in outpatient medical visit access between sexually and gender diverse (SGD) and non-SGD cohorts found in this study highlight priorities for culturally responsive…
, , , et al
JCP
Suicide Crisis Syndrome Assessment and ED Readmission
Original Research

October 23, 2024

Diagnosis of suicide crisis syndrome reduced readmission risk by approximately 72% for any reason and almost 75% for suicidal presentations.
, , , et al
JCP
Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans
Original Research

October 23, 2024

Subthreshold PTSD affects 3.5% of US military veterans and is associated with increased rates of psychiatric disorders, suicidal thoughts and behaviors, and functional difficulties.
, , , et al
JCP
Symptomatic Remission and Overall Recovery From BPD
Original Research

October 23, 2024

Over 24 years, patients with BPD were significantly slower to achieve remission or recovery than patients with other personality disorders. Ultimately, however, both groups achieved similarly high rates of…
, , , et al
JCP
Gepirone-ER and Sexual Function in Patients with MDD
Original Research

October 21, 2024

Rates of sexual side effects and treatment-emergent sexual dysfunction with gepirone-ER were similar to placebo and lower than sexual side effects reported for SSRIs.
, ,
JCP
Fluctuating ADHD in the Multimodal Treatment of ADHD (MTA) Study
Original Research

October 16, 2024

This study demonstrates that ADHD fluctuations are common and substantive and that, when remitted, individuals with fluctuating ADHD can successfully manage increased responsibilities.
, , , et al
JCP
Cannabis and Attention Deficit Disorder in Community Mental Health
Brief Report

October 14, 2024

The finding that 73% of patients with both ADHD and cannabis use were prescribed stimulant medications necessitates enhanced training and education for clinicians on appropriate prescription of stimulants.
, , , et al
JCP
Optimizing Recovery: Comprehensive Care Pathways for Depression
Insights

October 7, 2024

In this video, Dr. Jay Fournier discusses the challenges of outpatient depression care, including access issues, placebo response, and maintaining sustained remission. He outlines a stepped approach to treatment…
JCP
Surgical Interventions in Treatment Resistant Depression
Insights

October 7, 2024

Patricio Riva Posse, MD, discusses advanced surgical interventions for treatment-resistant depression, including vagus nerve and deep brain stimulation. This presentation explores relapse rates, alternative therapies, and the potential for…
JCP
Neurosteroids and Postpartum Depression
Insights

October 7, 2024

In this video, Samantha Meltzer-Brody, MD, MPH, discusses the use of brexanolone and zuranolone, novel neurosteroids for treating postpartum depression, focusing on their mechanisms, rapid efficacy, and clinical trial…
JCP
Ketamine/Esketamine in Bipolar Depression in a Clinical Setting
Original Research

October 2, 2024

In a small sample of patients with bipolar depression treated with ketamine/esketamine, no evidence of mania or hypomania was seen during acute treatment.
, , , et al
JCP
Suicide Risk Evaluation and Advanced AI Models
Original Research

October 2, 2024

This study explored how ChatGPT-3.5 and ChatGPT-4 assess suicide risk factors like previous attempts, gender, and age, focusing on their predictions about different types of suicidal behavior.
, ,

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe